Table 1 Clinical and histopathological patient characteristics in ICON and NEOSTAR cohorts.

From: Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Patient cohorts

ICON (chemotherapy) (n = 28)

NEOSTAR (ICIs) (n = 44)

 

Mean (SD)

Mean (SD)

Age (yr)

64.4 (8.8)

65.6 (8.3)

 

n (%)

n (%)

Sex

   Female

14 (50)

16 (36)

   Male

14 (50)

28 (64)

Histology

   Adenocarcinoma

19 (68)

26 (59)

   Squamous cell

9 (32)

17 (39)

   Adenosquamous

0

1 (2)

Clinical Stage

   Stage I

1 (3)

23 (52)

   Stage II

12 (43)

12 (27)

   Stage III

15 (54)

9 (20)

Smoking

   Never

5 (18)

8 (18)

   Former

23 (82)

26 (59)

   Current

0

10 (23)

  1. n, Number of patients. ICON ImmunogenomiC prOfiling in Non-small cell lung cancer, ICIs immune checkpoint inhibitors, SD standard deviation.
Back to article page